Transenterix Inc (NYSEAMERICAN:TRXC)’s share price gapped down before the market opened on Thursday . The stock had previously closed at $2.16, but opened at $2.11. Transenterix shares last traded at $2.03, with a volume of 2720492 shares.

A number of equities analysts recently commented on the stock. Stifel Nicolaus raised their price target on shares of Transenterix from $3.75 to $4.00 and gave the stock a “buy” rating in a research report on Tuesday, October 31st. Ladenburg Thalmann Financial Services set a $5.00 price target on shares of Transenterix and gave the stock a “buy” rating in a research report on Friday, October 20th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and two have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $2.61.

In other Transenterix news, CFO Joseph P. Slattery sold 529,609 shares of the firm’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $2.80, for a total value of $1,482,905.20. Following the transaction, the chief financial officer now directly owns 440,974 shares of the company’s stock, valued at approximately $1,234,727.20. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Todd Pope sold 600,000 shares of the firm’s stock in a transaction dated Wednesday, October 18th. The shares were sold at an average price of $3.68, for a total transaction of $2,208,000.00. Following the completion of the transaction, the insider now directly owns 462,644 shares in the company, valued at $1,702,529.92. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,462,609 shares of company stock worth $4,666,595.

An institutional investor recently raised its position in Transenterix stock. Ladenburg Thalmann Financial Services Inc. lifted its stake in shares of Transenterix Inc (NYSEAMERICAN:TRXC) by 87.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 79,150 shares of the medical instruments supplier’s stock after purchasing an additional 37,000 shares during the quarter. Ladenburg Thalmann Financial Services Inc. owned 0.05% of Transenterix worth $113,000 as of its most recent filing with the Securities and Exchange Commission.

COPYRIGHT VIOLATION WARNING: This article was first published by Watch List News and is the sole property of of Watch List News. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://www.watchlistnews.com/transenterix-trxc-shares-gap-down-to-2-11/1767701.html.

Transenterix Company Profile

TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.

Receive News & Ratings for Transenterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix and related companies with MarketBeat.com's FREE daily email newsletter.